Back to photostream

Oral Solids Drive CMO Powerhouse: A $52B Market by 2031 - 1

The global oral solid dosage contract manufacturing market is experiencing strong growth due to cost-effective production, technological advancements, and patient compliance improvements. This article provides a comprehensive analysis of the market's current landscape, market segmentation, regional dynamics, and outlook.

 

Market Overview

The oral solid dosage contract manufacturing market is experiencing significant growth, valued at USD 32.36 billion in 2022 and projected to reach USD 52.60 billion by 2031 at a 5.72% CAGR. This growth is attributed to the affordability, ease of production, and patient convenience of oral solid dosage forms like tablets and capsules, widely used in the pharmaceutical industry.

 

Key Growth Drivers

The oral solid dosage contract manufacturing market is expanding due to the complexity of new drug compounds and the development of sustained-release formulations. The focus on enhancing bioavailability and reducing medication administration frequency has led to the use of advanced technologies to improve the delivery and efficacy of oral solid dosage forms.

#health #pharma #market #medicine #business #growth #healthcare #manufacturing #tablet #biology #sustainability #tech #technology #growthmarketing #innovation #bcg #deloitte #kpmg #consulting #cognicraft__solutions #revolution #accenture CogniCraft Solutions

12 views
0 faves
0 comments
Uploaded on January 15, 2024